Clinical Pharmacokinetics and Pharmacodynamics of Cefiderocol Muhammad BilalLobna El TabeiMax Taubert Review Article Open access 22 August 2021 Pages: 1495 - 1508
Review of Transporter Substrate, Inhibitor, and Inducer Characteristics of Cladribine Robert HermannPeter KrajcsiAlain Munafo Review Article Open access 26 August 2021 Pages: 1509 - 1535
Impact of Inflammation on Cytochromes P450 Activity in Pediatrics: A Systematic Review Camille LenoirFrédérique RodieuxCaroline F. Samer Systematic Review Open access 31 August 2021 Pages: 1537 - 1555
Exposures of Phenylacetic Acid and Phenylacetylglutamine Across Different Subpopulations and Correlation with Adverse Events Xiaofeng WangJack TsengRegis A. Vilchez Original Research Article Open access 14 June 2021 Pages: 1557 - 1567
Influence of CYP2D6 Phenotypes on the Pharmacokinetics of Aripiprazole and Dehydro-Aripiprazole Using a Physiologically Based Pharmacokinetic Approach Lisa Alina KnellerPablo ZubiaurGeorg Hempel Original Research Article Open access 14 June 2021 Pages: 1569 - 1582
Pharmacokinetic Correlates of Once-Monthly Paliperidone Palmitate-Related Adverse Drug Reactions Georgios SchoretsanitisEkkehard HaenMichael Paulzen Original Research Article 18 June 2021 Pages: 1583 - 1589
Physiologically Based Pharmacokinetic Modeling of Meropenem in Preterm and Term Infants Samit GangulyAndrea N. Edgintonthe Best Pharmaceuticals for Children Act-Pediatric Trials Network Steering Committee Original Research Article 22 June 2021 Pages: 1591 - 1604
A Population Pharmacokinetic Model of Macitentan and Its Active Metabolite Aprocitentan in Healthy Volunteers and Patients with Pulmonary Arterial Hypertension Roberta BartolucciAnne-Gaëlle DosneItalo Poggesi Original Research Article 23 June 2021 Pages: 1605 - 1619
Population Cellular Kinetics of Lisocabtagene Maraleucel, an Autologous CD19-Directed Chimeric Antigen Receptor T-Cell Product, in Patients with Relapsed/Refractory Large B-Cell Lymphoma Ken OgasawaraMichael DoddsJeff Smith Original Research Article Open access 14 June 2021 Pages: 1621 - 1633
Correction to: Population Cellular Kinetics of Lisocabtagene Maraleucel, an Autologous CD19-Directed Chimeric Antigen Receptor T-Cell Product, in Patients with Relapsed/Refractory Large B-Cell Lymphoma Ken OgasawaraMichael DoddsJeff Smith Correction Open access 03 July 2021 Pages: 1635 - 1635